Ivabradine in Prevention of POAF after CABG surgery

Efficacy of perioperative bisoprolol and ivabradine versus bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202103543569729

Enrollment

Registered

2021-03-08

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiology

Interventions

Ivabradine and bisoprolol

Bisoprolol alone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will be scheduled for coronary artery bypass graft surgery (CABG).

Exclusion criteria

Exclusion criteria: - Patients with atrial fibrillation or past history of atrial fibrillation. - Concurrent valve surgery or valvular heart diseases (including moderate to severe mitral or aortic regurgitation or stenosis). - Preoperative heart rate of 2mg/dl), end stage renal disease (ESRD) on maintenance dialysis. - Patients on chronic amiodarone or digoxin therapy. - Poor left ventricular function (Ejection fraction < 35 %). - Emergency operation.

Design outcomes

Primary

Measure	Time frame
Atrial fibrillation	—

Secondary

Measure	Time frame
Heart rate	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026